Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
957 | 10802 | 36.5 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PET CT | authKW | 779027 | 8% | 31% | 901 |
2 | NUCL MED | address | 679916 | 29% | 8% | 3167 |
3 | PET | authKW | 473413 | 12% | 12% | 1349 |
4 | POSITRON EMISSION TOMOGRAPHY | authKW | 418900 | 12% | 12% | 1253 |
5 | PSMA | authKW | 350562 | 2% | 69% | 180 |
6 | PET MRI | authKW | 291755 | 2% | 59% | 174 |
7 | PROSTATE SPECIFIC MEMBRANE ANTIGEN | authKW | 269997 | 1% | 65% | 147 |
8 | FDG | authKW | 258058 | 3% | 27% | 340 |
9 | JOURNAL OF NUCLEAR MEDICINE | journal | 250423 | 9% | 9% | 949 |
10 | ATTENUATION CORRECTION | authKW | 232917 | 2% | 38% | 219 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 188605 | 51% | 1% | 5498 |
2 | Oncology | 13524 | 20% | 0% | 2140 |
3 | Respiratory System | 1051 | 3% | 0% | 343 |
4 | Urology & Nephrology | 663 | 3% | 0% | 330 |
5 | Engineering, Biomedical | 557 | 2% | 0% | 257 |
6 | Nuclear Science & Technology | 279 | 2% | 0% | 247 |
7 | Medicine, Research & Experimental | 267 | 3% | 0% | 335 |
8 | Chemistry, Medicinal | 231 | 2% | 0% | 235 |
9 | Neuroimaging | 202 | 1% | 0% | 74 |
10 | Surgery | 159 | 4% | 0% | 486 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCL MED | 679916 | 29% | 8% | 3167 |
2 | PET | 70464 | 3% | 9% | 294 |
3 | RADIOL | 61366 | 21% | 1% | 2283 |
4 | PET CT | 53853 | 1% | 22% | 86 |
5 | MOL MED PHARMACOL | 45764 | 2% | 8% | 204 |
6 | NUCL MED SERV | 43197 | 2% | 7% | 218 |
7 | NUCL MED MOL IMAGING | 40971 | 1% | 11% | 129 |
8 | SECT JARA BRAIN | 39723 | 0% | 94% | 15 |
9 | MOL IMAGING | 38969 | 2% | 6% | 222 |
10 | CRUMP MOL IMAGING | 34256 | 1% | 17% | 72 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NUCLEAR MEDICINE | 250423 | 9% | 9% | 949 |
2 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 232113 | 5% | 16% | 513 |
3 | MOLECULAR IMAGING AND BIOLOGY | 85763 | 2% | 18% | 171 |
4 | ANNALS OF NUCLEAR MEDICINE | 76644 | 2% | 12% | 228 |
5 | NUCLEAR MEDICINE COMMUNICATIONS | 58091 | 3% | 7% | 293 |
6 | NUCLEAR MEDICINE AND BIOLOGY | 57734 | 3% | 7% | 275 |
7 | EJNMMI RESEARCH | 36154 | 1% | 17% | 75 |
8 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35898 | 1% | 15% | 83 |
9 | CLINICAL NUCLEAR MEDICINE | 22803 | 2% | 4% | 233 |
10 | NUKLEARMEDIZIN-NUCLEAR MEDICINE | 22716 | 1% | 8% | 97 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PET CT | 779027 | 8% | 31% | 901 | Search PET+CT | Search PET+CT |
2 | PET | 473413 | 12% | 12% | 1349 | Search PET | Search PET |
3 | POSITRON EMISSION TOMOGRAPHY | 418900 | 12% | 12% | 1253 | Search POSITRON+EMISSION+TOMOGRAPHY | Search POSITRON+EMISSION+TOMOGRAPHY |
4 | PSMA | 350562 | 2% | 69% | 180 | Search PSMA | Search PSMA |
5 | PET MRI | 291755 | 2% | 59% | 174 | Search PET+MRI | Search PET+MRI |
6 | PROSTATE SPECIFIC MEMBRANE ANTIGEN | 269997 | 1% | 65% | 147 | Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN | Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN |
7 | FDG | 258058 | 3% | 27% | 340 | Search FDG | Search FDG |
8 | ATTENUATION CORRECTION | 232917 | 2% | 38% | 219 | Search ATTENUATION+CORRECTION | Search ATTENUATION+CORRECTION |
9 | PET MR | 229128 | 1% | 71% | 115 | Search PET+MR | Search PET+MR |
10 | SUV | 213202 | 1% | 49% | 154 | Search SUV | Search SUV |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GULYAS, B , HALLDIN, C , (2012) NEW PET RADIOPHARMACEUTICALS BEYOND FDG FOR BRAIN TUMOR IMAGING.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 56. ISSUE 2. P. 173 -190 | 162 | 68% | 52 |
2 | HERHOLZ, K , (2017) BRAIN TUMORS: AN UPDATE ON CLINICAL PET RESEARCH IN GLIOMAS.SEMINARS IN NUCLEAR MEDICINE. VOL. 47. ISSUE 1. P. 5 -17 | 158 | 76% | 0 |
3 | JADVAR, H , (2012) MOLECULAR IMAGING OF PROSTATE CANCER: PET RADIOTRACERS.AMERICAN JOURNAL OF ROENTGENOLOGY. VOL. 199. ISSUE 2. P. 278-291 | 145 | 74% | 36 |
4 | MAURER, T , EIBER, M , SCHWAIGER, M , GSCHWEND, JE , (2016) CURRENT USE OF PSMA - PET IN PROSTATE CANCER MANAGEMENT.NATURE REVIEWS UROLOGY. VOL. 13. ISSUE 4. P. 226 -235 | 78 | 74% | 16 |
5 | EVANGELISTA, L , BRIGANTI, A , FANTI, S , JONIAU, S , RESKE, S , SCHIAVINA, R , STIEF, C , THALMANN, GN , PICCHIO, M , (2016) NEW CLINICAL INDICATIONS FOR F-18/C-11-CHOLINE, NEW TRACERS FOR POSITRON EMISSION TOMOGRAPHY AND A PROMISING HYBRID DEVICE FOR PROSTATE CANCER STAGING: A SYSTEMATIC REVIEW OF THE LITERATURE.EUROPEAN UROLOGY. VOL. 70. ISSUE 1. P. 161 -175 | 72 | 81% | 13 |
6 | KIESS, AP , BANERJEE, SR , MEASE, RC , ROWE, SP , RAO, A , FOSS, CA , CHEN, Y , YANG, X , CHO, SY , NIMMAGADDA, S , ET AL (2015) PROSTATE-SPECIFIC MEMBRANE ANTIGEN AS A TARGET FOR CANCER IMAGING AND THERAPY.QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 59. ISSUE 3. P. 241 -268 | 109 | 80% | 12 |
7 | ALBERT, NL , WELLER, M , SUCHORSKA, B , GALLDIKS, N , SOFFIETTI, R , KIM, MM , LA FOUGERE, C , POPE, W , LAW, I , ARBIZU, J , ET AL (2016) RESPONSE ASSESSMENT IN NEURO-ONCOLOGY WORKING GROUP AND EUROPEAN ASSOCIATION FOR NEURO-ONCOLOGY RECOMMENDATIONS FOR THE CLINICAL USE OF PET IMAGING IN GLIOMAS.NEURO-ONCOLOGY. VOL. 18. ISSUE 9. P. 1199 -1208 | 101 | 85% | 2 |
8 | VON EYBEN, FE , KAIREMO, K , (2014) META-ANALYSIS OF C-11-CHOLINE AND F-18-CHOLINE PET/CT FOR MANAGEMENT OF PATIENTS WITH PROSTATE CANCER.NUCLEAR MEDICINE COMMUNICATIONS. VOL. 35. ISSUE 3. P. 221-230 | 78 | 99% | 27 |
9 | ZAIDI, H , EL NAQA, I , (2010) PET-GUIDED DELINEATION OF RADIATION THERAPY TREATMENT VOLUMES: A SURVEY OF IMAGE SEGMENTATION TECHNIQUES.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 37. ISSUE 11. P. 2165 -2187 | 121 | 63% | 121 |
10 | VAN WAARDE, A , ELSINGA, PH , (2008) PROLIFERATION MARKERS FOR THE DIFFERENTIAL DIAGNOSIS OF TUMOR AND INFLAMMATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 31. P. 3326-3339 | 141 | 72% | 22 |
Classes with closest relation at Level 2 |